new bio opportunity, page-8

I dunno... my portfolio's looking absolutely disgusting, but this is probably the shining star right now (I know... it's THAT bad)
At least these guys have cash to last at least two more quarters, seem to be (genuinely) attempting to reduce costs, and are still getting the odd contract here and there. Once we're out of this global economic rut, we'll suddenly remember the potential of this company taking part in what is a massive growth industry.
If it makes you feel any better, take a look at RER, ISN, AOP, GGP... they're all stinkers and have lost me a bomb. At least this one seems to have some medium term growth potential!